INDEX logo

InDex Pharmaceuticals Holding AB (publ) Stock Price

OM:INDEX Community·SEK 286.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 1 Fair Values set on narratives written by author

INDEX Share Price Performance

SEK 0
0.00 (0.00%)
SEK 0
0.00 (0.00%)
Sorry, there is currently no price data for this company.

INDEX Community Narratives

There are no narratives available yet.

Snowflake Analysis

Flawless balance sheet and slightly overvalued.

3 Risks
1 Reward

InDex Pharmaceuticals Holding AB (publ) Key Details

SEK 108.3m

Revenue

SEK 4.0m

Cost of Revenue

SEK 104.3m

Gross Profit

SEK 160.8m

Other Expenses

-SEK 56.5m

Earnings

Last Reported Earnings
Mar 31, 2024
Next Reporting Earnings
Aug 20, 2024
-0.11
96.28%
-52.13%
0%
View Full Analysis

About INDEX

Founded
2000
Employees
4
CEO
Jenny Sundqvist
WebsiteView website
www.indexpharma.com

InDex Pharmaceuticals Holding AB (publ) engages in the research and development of pharmaceuticals for immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.

Recent INDEX News & Updates

Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Jun 13
Market Might Still Lack Some Conviction On InDex Pharmaceuticals Holding AB (publ) (STO:INDEX) Even After 35% Share Price Boost

Recent updates

No updates